Court preliminarily approves Inotiv derivative settlement; $2.49M from insurance for company benefit

Inotiv, Inc.

Preliminary approval order issued Jan 7, 2026; final hearing set for Mar 18, 2026 at 9:00 a.m.
Settlement includes $2,490,000 payment from insurance for Inotiv's benefit, used for securities class action settlement.
Plaintiffs' attorneys' fees up to $2,250,000, subject to court approval, also funded by insurance.
Inotiv to adopt corporate governance measures as part of settlement; no admission of liability by defendants.
Derivative actions arose from Nov 2021 Envigo acquisition and later USDA inspections at Cumberland facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.